Master of Biotechnology Graduate, Voracious reader, passionate about teaching with an excellent knack for communicating knowledge.

Master of Biotechnology with research.

Understanding the sell-out process in Oncology within Oncology centres of Excellence for the project "Australian Hospital Oncology Medicine Utilisation Landscape” with the prime focus being The Peter MacCallum Cancer Centre, Melbourne. • Primary and secondary market research, comprehensive literature review, conducted field interviews by telephone, emails and in-person meetings. • Data analysis by team corroboration and fact-checking through reliable sources. • Preparing in-depth reports, strengthening written and verbal communication. • Market analysis (market size, market potential) for oncology drug utilization and procurement, carried out by effective time management, flexibility and constant feedback from IQVIA • Project management, planning and execution for medicine utilization landscape and assessment of data systems in oncology. Liaison with a multitude of health professionals from PMCC during the tenure. Practiced leadership by effective speaking, critical thinking and taking initiative, negotiations in persuasion and information assertion.

Recombinant antibody production for sub-unit vaccine development- the CEPI (Coalition for Epidemic Preparedness Innovations) Project. • Optimisation of antibody development and culture protocol, production of various recombinant proteins and antibodies. • Carried out modified purification regime, protein folding studies and visualisation by collaboration of extensive literature review through reliable information management. • Mass Spectrometry analysis, large-scale production, fostering research, analytical, numeracy and dependability skills. • One of the cultures was used for the affinity capture of novel subunit vaccines based on the Molecular Clamp Technology platform developed by the ‘University of Queensland’ to combat against deadly infectious diseases as a platform for application of the antibody production. This technology is currently being used to produce a vaccine candidate against COVID-19 at CSIRO. This further expanded existing skills in goal setting and working independently through constant feedback by seniors. • Undergone cGMP training.

Understanding the science behind stem cells, their handling procedures and applications. • Cell culture with applications in advanced Recombinant Molecular Techniques applied in stem cell research.

Understanding biosimilars, their applications thereof and performing cell culture and microbial culture techniques independently. • Worked in the downstream processing department for antibody development, cell culturing and large-scale production, analytical development department for protein analysis • Quality Assessment and Quality Control, Microbial and Biobulk Management department, monitoring and checking anti-bacterial and anti-fungal effects of formulated biosimilars.